Akiyama T, Ikegami M, Imanishi M, Ishii T, Nishioka T, Uemura T, Kunikata S, Mitsubayashi S, Kanda H, Matsuura T
Department of Urology, Kinki University School of Medicine.
Nihon Hinyokika Gakkai Zasshi. 1990 Nov;81(11):1680-5. doi: 10.5980/jpnjurol1989.81.1680.
Both D-dimer and E fragments in urinary FDP were determined in renal transplantation patients. Urinary D-dimer fragments increased in 14 out of 20 acute rejections (70.0%) and in 6 out of 18 chronic rejections (33.3%). Urinary E fragments increased in 8 out of 9 acute rejections (88.9%) and in 4 out of 5 chronic rejections (80.0%). It is suggested that urinary FDP-E fragment is a better indicator to detect or predict rejection than the whole Urinary FDP. The appearance of D-dimer in the urine indicates intravascular coagulation in glomeruli followed by a secondary fibrinolysis in the course of the rejection reaction. The urinary D-dimer/FDP ratio which was used as the indicator of fibrinolytic activity in glomeruli was obtained in various conditions of renal transplants. The ratios were relatively high in the urines from well functioning grafts. This ratio deteriorated at the onset of rejection crisis and tended to go upward during the course of the recovery when the rejection was reversible. In the cases of irreversible acute rejection and chronic rejection, these ratios remained at a low level. D-dimer/FDP ratio might be useful indicator to predict the reversibility of rejection and the prognosis of renal allograft. Furthermore, these findings suggest that fibrinolytic and thrombolytic therapy by the tissue-type plasminogen activator (t-PA) along with immunosuppressive drugs might be more effective for the treatment of these rejections.
对肾移植患者测定了尿纤维蛋白降解产物(FDP)中的D - 二聚体和E片段。20例急性排斥反应中有14例(70.0%)尿D - 二聚体片段升高,18例慢性排斥反应中有6例(33.3%)升高。9例急性排斥反应中有8例(88.9%)尿E片段升高,5例慢性排斥反应中有4例(80.0%)升高。提示尿FDP - E片段比整个尿FDP是检测或预测排斥反应更好的指标。尿中出现D - 二聚体表明在排斥反应过程中肾小球内发生血管内凝血,随后继发纤溶。在肾移植的各种情况下获得了用作肾小球纤溶活性指标的尿D - 二聚体/FDP比值。在功能良好的移植肾的尿中该比值相对较高。在排斥危机发作时该比值恶化,当排斥反应可逆且处于恢复过程中时趋于上升。在不可逆急性排斥和慢性排斥的病例中,这些比值保持在低水平。D - 二聚体/FDP比值可能是预测排斥反应可逆性和肾移植预后的有用指标。此外,这些发现提示组织型纤溶酶原激活剂(t - PA)联合免疫抑制药物进行纤溶和溶栓治疗可能对这些排斥反应的治疗更有效。